Evidence map›Paper›PMID 29632538›Full record

ReviewFrontiers in immunology2018

Pathogen Recognition by CD4 Effectors Drives Key Effector and Most Memory Cell Generation Against Respiratory Virus.

Priyadharshini Devarajan, Michael C Jones, Olivia Kugler-Umana, Allen M Vong, Jingya Xia, Susan L Swain

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. CD4 T Helper Cell Subsets and Related Human Immunological Disorders.International journal of molecular sciences · 2020
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Priyadharshini DevarajanDepartment of Pathology, University of Massachusetts Medical School, Worcester, MA, United States.
Michael C JonesDepartment of Pathology, University of Massachusetts Medical School, Worcester, MA, United States.
Olivia Kugler-UmanaDepartment of Pathology, University of Massachusetts Medical School, Worcester, MA, United States.
Allen M VongDepartment of Pathology, University of Massachusetts Medical School, Worcester, MA, United States.
Jingya XiaDepartment of Pathology, University of Massachusetts Medical School, Worcester, MA, United States.
Susan L SwainDepartment of Pathology, University of Massachusetts Medical School, Worcester, MA, United States.

Funding

MOLECULAR BIOLOGY COREP01AG021600 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HAYNES, LAURA · 2003 to 2016
$24.4M
T cell memory to TB in the lungP01AI046530 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SWAIN, SUSAN L · 1999 to 2013
$22.2M
T cell and transgenic core U19AI109858 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI HUSEBY, ERIC S · 2014 to 2018
$11.9M
TRAINING IN THE NEUROPLASTICITY OF AGINGT32AG000216 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KOO, EDWARD H. · 1992 to 2017
$8.4M
TRAINING IN IMMUNOLOGY (COMPETITIVE RENEWAL OF AI07439)T32AI007349 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 1989 to 2024
$4.5M
Defining a memory checkpoint for CD4 T cellsR01AI118820 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SWAIN, SUSAN L · 2015 to 2019
$2.1M
Virus induced immunopathologyR01AI081675 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WELSH, RAYMOND M · 2009 to 2013
$2.0M
Training in the Molecular Basis of Autoimmunity and AutoinflammationT32AI132152 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Katherine A. Fitzgerald, Ann Marshak-Rothstein · 2018 to 2026
$1.6M
VACCINE STRATEGIES TO CIRCUMVENT AGE-ASSOCIATED IMMUNE DEFECTSR21AG058758 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SWAIN, SUSAN L · 2018 to 2019
$461k
Maintaining Robust T Cell Immunity For Broad Protection Against InfluenzaR21AI146532 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SWAIN, SUSAN L · 2019 to 2020
$461k
NIAID NIH HHS P01 AI046530NIAID NIH HHS R01 AI081675NIAID NIH HHS R01 AI118820NIAID NIH HHS R21 AI146532NIAID NIH HHS T32 AI007349NIAID NIH HHS T32 AI132152NIAID NIH HHS U19 AI109858NIA NIH HHS P01 AG021600NIA NIH HHS T32 AG000216
6 · The paper itself

Abstract

Although much is known about the mechanisms by which pathogen recognition drives the initiation of T cell responses, including those to respiratory viruses, the role of pathogen recognition in fate decisions of T cells once they have become effectors remains poorly defined. Here, we review our recent studies that suggest that the generation of CD4 T cell memory is determined by recognition of virus at an effector "checkpoint." We propose this is also true of more highly differentiated tissue-restricted effector cells, including cytotoxic "ThCTL" in the site of infection and T

Indexed as

Immunologic MemoryAnimalsB-LymphocytesCD4-Positive T-LymphocytesCellular SenescenceHost-Pathogen InteractionsHumansImmunityRespirovirus InfectionsSignal TransductionViral VaccinesViral VaccinesCD4 T cellsimmune memoryinfluenzapathogen recognitionTFHThCTLvirus

Identifiers

PMID29632538
PMCPMC5879149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.